NDA Almost Ready, MannKind Exubera(nt) About Chances For Inhaled-Insulin Partner
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite safer-seeming profile, many skeptical of Afresa after flameout of Pfizer’s product.